Opus Genetics, Inc.
IRD
$5.19
$0.163.18%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
Tickeron - Technical Analysis
3/17/2026
-
MarketBeat
3/16/2026
-
MarketBeat
3/16/2026
-
Ticker Report
3/14/2026
-
Tickeron - Stocks
3/13/2026
-
TipRanks Financial Blog
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
Tickeron - Stocks
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
Ticker Report
3/12/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
Insider Monkey
3/12/2026
-
Tickeron - Stocks
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
Tickeron - Technical Analysis
3/11/2026
-
Simply Wall St
3/10/2026
-
TipRanks Financial Blog
3/10/2026
-
Zacks Investment Research
3/10/2026
-
Seeking Alpha - Healthcare
3/10/2026
-
Benzinga
3/10/2026
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
984 884 6030
Address
8 Davis Drive
Durham, NC 27713
Durham, NC 27713
Country
Year Founded
Business Description
Sector
Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types...
more